GlaxoSmithKline News

This is selected news for GlaxoSmithKline, which is filed under Sectors / Healthtech. There are 32.9K news items for this page. GlaxoSmithKline is occasionally combined with GSK, Eli Lilly and Boehringer Ingelheim in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/24/2022 Non-opioid Analgesic Patch Market Top Key Players 2022-2031 | GlaxoSmithKline Plc, Pfizer, Teikoku Seiyaku
Non-opioid Analgesic Patch Market Top Key Players 2022-2031 GlaxoSmithKline Plc, Pfizer, Teikoku Seiyaku Market.us Study of Non-opioid Analgesic Patch Market allows marketers to keep abreast of consumer trends and identify segments that can help them grow their market share. This research helps readers determine how customers perceive the ...
farsuna.com
9/23/2022 Drug Companies Withdraw PARPi Indications for Ovarian Cancer
... 2022 Multiple drug companies have recently withdrawn their respective PARP inhibitors for heavily pretreated ovarian cancer patients, citing data showing an increased risk for death. In a September 14 letter to healthcare professionals, GlaxoSmithKline (GSK) announced the voluntary withdrawal of niraparib (Zejula) for fourth-line treatment in adults with advanced ...
Medscape
9/23/2022 Global Nephrotic Syndrome Diagnostics & Therapeutics Market 2022: Featuring Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline & More - ResearchAndMarkets.com | Business Wire
... Blood Thinners) 6. Regional Analysis 7. Company Profiles Companies Mentioned Abbott Laboratories Asahi Kasei Pharma Corp. AstraZeneca PLC Aurinia Pharmaceuticals Inc. Bristol-Myers Squibb Co. DaVita Inc. Eli Lilly and Co. GeneDx Inc. GlaxoSmithKline PLC Johnson and Johnson Services Inc. Mallinckrodt LLC Novartis International AG Pfizer Inc. Sanofi SA ZyVersa ...
Business Wire
9/23/2022 Global Nephrotic Syndrome Diagnostics & Therapeutics Market 2022: Featuring Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline & More - ResearchAndMarkets.com
... Blood Thinners) 6. Regional Analysis 7. Company Profiles Companies Mentioned - Abbott Laboratories - Asahi Kasei Pharma Corp. - AstraZeneca PLC - Aurinia Pharmaceuticals Inc. - Bristol-Myers Squibb Co. - DaVita Inc. - Eli Lilly and Co. - GeneDx Inc. - GlaxoSmithKline PLC - Johnson and Johnson Services Inc. - Mallinckrodt LLC - Novartis International AG - Pfizer Inc. - Sanofi SA - ZyVersa ...
Business Wire
9/23/2022 7 Stocks to Buy That Can Soar in Good Times or in Bad
... companies and governments will find necessary even during recessions, such as energy and cybersecurity. Here are seven stocks to buy regardless of where the economy is headed. Eli Lilly $311.32 McDonald's $247.91 GlaxoSmithKline $30.02 Dollar Tree $139.33 Dollar General $240.25 Cheniere Energy $166.29 Fortinet $48.74 Eli Lilly (LLY) The ...
investorplace.com
9/22/2022 Bioelectric Medicine Market to Surpass US$ 22.3 Billion at a CAGR of 7.2% by 2028 | GlaxoSmithKline, Medtronic Plc mediaworldtoday.com
9/22/2022 Bioelectric Medicine Market to Surpass US$ 22.3 Billion at a CAGR of 7.2% by 2028 | GlaxoSmithKline, Medtronic Plc - Religion News Today - EIN Presswire einnews.com
9/22/2022 Bioelectric Medicine Market to Surpass US$ 22.3 Billion at a CAGR of 7.2% by 2028 | GlaxoSmithKline, Medtronic Plc smallbusinessnewswatch.com
9/22/2022 Oral Care Market Size, Share, Growth and Forecast to 2026 PRSync
9/21/2022 Protein Supplements Global Market Report 2022 Yahoo News
9/20/2022 Global Hematologic Malignancies Therapeutics Market to Grow at a CAGR of ~12% during 2022-2031; Market to Expand Owing to the Increasing Number of Patients with Leukemia, and Other Blood Cancers – Kenneth Research Yahoo News
9/20/2022 Pfizer inks deal with tech company for up to $110M | Digital Health Business & Technology Modern Healthcare
9/20/2022 Systemic Lupus Erythematosus Treatment Market to See Booming Growth | Bristol-Myers Squibb Company, AstraZeneca, GlaxoSmithKline, Aurinia - Digital Journal digitaljournal.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Shipping & Logistics Industry Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Mining Industry Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Education News Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Media Industry Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - US Politics Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Science News Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc, - Residential Real Estate Today - EIN Presswire einnews.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc smallbusinessnewswatch.com
9/19/2022 Shigella Vaccines Future of the Market Adds New Dimension to Innovations till 2028 | Novartis, GlaxoSmithKline plc mediaworldtoday.com
9/19/2022 South America Virus-like Particles Market to Grow at a CAGR of 7.2% to reach US$ 324.57 million from 2021 to 2028 PRSync
9/19/2022 Outlook on the Cerumen Removal Global Market to 2030 - Featuring Medline, Henry Schein, Cardinal Health and Cipla Among Others - ResearchAndMarkets.com | Business Wire Business Wire
9/19/2022 Outlook on the Cerumen Removal Global Market to 2030 - Featuring Medline, Henry Schein, Cardinal Health and Cipla Among Others - ResearchAndMarkets.com Business Wire